Aquit develops preventive treatments for infections in fish that replace antibiotics, improve survival rates, and boost natural immunity.
Aquit has raised $832K in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2025.
Aquit's investors include Hatch Blue Ltd, The Ganesha Lab, GRID EXPONENTIAL, Ocean Impact Organisation, Bright Tide.
Aquit is headquartered in Viña Del Mar, Chile.
Aquit develops preventive treatments for infections in fish that replace antibiotics, improve survival rates, and boost natural immunity.
Aquit is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aquit — Funding & Investors." VCBacked, March 19, 2025, https://www.vcbacked.co/company/aquit. Accessed August 14, 2026.
VCBacked. (2025). Aquit — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/aquit
{{cite web |title=Aquit — Funding & Investors |url=https://www.vcbacked.co/company/aquit |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated